OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents
Mohammad M. Al‐Sanea, Abdelrahman Hamdi, Simone Brogi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Synthesis, in silico ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents
Nagwa M. Abdelazeem, Wael M. Aboulthana, Ashraf S. Hassan, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 5, pp. 102025-102025
Open Access | Times Cited: 10

Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations
Sara Masoudinia, Marjaneh Samadizadeh, Maliheh Safavi, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5

S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 4

Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights
Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A. Ewes, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 12

COX inhibitory profiles of a series of thiadiazole-benzothiazole hybrids
Ahmet Özdemır, Halide Edip Temel
European Journal of Life Sciences (2024) Vol. 3, Iss. 1, pp. 9-15
Open Access

Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors
Mohammad M. Al‐Sanea, Hani M. Hafez, Ahmed A. B. Mohamed, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5109-5127
Open Access

Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities
Abdelrahman Hamdi, Samar S. Tawfik, Ahmed R. Ali, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107951-107951
Closed Access

Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors
Marwa I. Serag, Samar S. Tawfik, Hassan M. Eisa, et al.
Drug Development Research (2024) Vol. 86, Iss. 1
Closed Access

Page 1

Scroll to top